Personalis, Inc. (PSNL)
PSNL Stock Price Chart
Explore Personalis, Inc. interactive price chart. Choose custom timeframes to analyze PSNL price movements and trends.
PSNL Company Profile
Discover essential business fundamentals and corporate details for Personalis, Inc. (PSNL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
20 Jun 2019
Employees
228.00
Website
https://www.personalis.comCEO
Christopher Hall
Description
Personalis, Inc. operates globally as a specialized cancer genomics firm. The company delivers advanced sequencing and data analysis capabilities, primarily supporting the development of novel cancer treatments and facilitating extensive genetic research initiatives. Central to their offerings is the NeXT Platform, which enables detailed data analysis of tumors and their surrounding immune microenvironments, even from small tissue or plasma samples. This platform encompasses several specialized solutions: ImmunoID Next for tissue-based tumor profiling; NeXT Liquid Biopsy for plasma analysis; NeXT Personal, a specific liquid biopsy designed for individual patient tumor tracking; the NeXT Dx Test, a genomic cancer profiling tool that identifies composite biomarkers for treatment guidance; and the sophisticated NeXT SHERPA and NeXT NEOPS for predicting neoantigens. Additionally, Personalis offers the ACE platform, utilized for diverse clinical and therapeutic applications like neoantigen prediction, biomarker identification, and the selection of new drug targets. Their clientele includes biopharmaceutical companies, academic institutions, non-profit organizations, and government entities. The company has established significant partnerships with organizations such as Mayo Clinic, MapKure, LLC, SpringWorks Therapeutics, Inc., and Moores Cancer Center. Personalis, Inc. was founded in 2011 and is based in Menlo Park, California.
PSNL Financial Timeline
Browse a chronological timeline of Personalis, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is -$0.25, while revenue estimate is $16.79m.
Earnings released on 7 May 2026
EPS came in at -$0.29 falling short of the estimated -$0.23 by -26.09%, while revenue for the quarter reached $15.47m , beating expectations by +6.81%.
Earnings released on 26 Feb 2026
EPS came in at -$0.26 surpassing the estimated -$0.31 by +16.13%, while revenue for the quarter reached $17.35m , beating expectations by +1.73%.
Earnings released on 4 Nov 2025
EPS came in at -$0.24 surpassing the estimated -$0.28 by +14.29%, while revenue for the quarter reached $14.50m , missing expectations by -14.94%.
Earnings released on 5 Aug 2025
EPS came in at -$0.23 surpassing the estimated -$0.25 by +8.00%, while revenue for the quarter reached $17.20m , missing expectations by -14.48%.
Earnings released on 6 May 2025
EPS came in at -$0.18 surpassing the estimated -$0.23 by +21.74%, while revenue for the quarter reached $20.61m , beating expectations by +18.32%.
Earnings released on 27 Feb 2025
EPS came in at -$0.23 surpassing the estimated -$0.32 by +28.13%, while revenue for the quarter reached $16.80m , beating expectations by +8.56%.
Earnings released on 6 Nov 2024
EPS came in at -$0.64 falling short of the estimated -$0.33 by -93.94%, while revenue for the quarter reached $25.71m , beating expectations by +65.54%.
Earnings released on 7 Aug 2024
EPS came in at -$0.24 surpassing the estimated -$0.34 by +29.41%, while revenue for the quarter reached $22.58m , beating expectations by +17.24%.
Earnings released on 8 May 2024
EPS came in at -$0.26 surpassing the estimated -$0.44 by +40.91%, while revenue for the quarter reached $19.53m , beating expectations by +6.35%.
Earnings released on 28 Feb 2024
EPS came in at -$0.46 surpassing the estimated -$0.53 by +13.21%, while revenue for the quarter reached $19.68m , missing expectations by -0.33%.
Earnings released on 7 Nov 2023
EPS came in at -$0.51 surpassing the estimated -$0.54 by +5.56%, while revenue for the quarter reached $18.25m , beating expectations by +7.46%.
Earnings released on 8 Aug 2023
EPS came in at -$0.50 surpassing the estimated -$0.56 by +10.71%, while revenue for the quarter reached $16.70m , beating expectations by +1.27%.
Earnings released on 3 May 2023
EPS came in at -$0.61 surpassing the estimated -$0.62 by +1.61%, while revenue for the quarter reached $18.86m , beating expectations by +8.70%.
Earnings released on 23 Feb 2023
EPS came in at -$0.67 falling short of the estimated -$0.65 by -3.08%, while revenue for the quarter reached $16.72m , beating expectations by +0.01%.
Earnings released on 2 Nov 2022
EPS came in at -$0.58 surpassing the estimated -$0.63 by +7.94%, while revenue for the quarter reached $14.86m , beating expectations by +6.23%.
Earnings released on 3 Aug 2022
EPS came in at -$0.60 surpassing the estimated -$0.63 by +4.76%, while revenue for the quarter reached $18.24m , beating expectations by +17.63%.
Earnings released on 4 May 2022
EPS came in at -$0.63 falling short of the estimated -$0.57 by -10.53%, while revenue for the quarter reached $15.23m , beating expectations by +6.17%.
Earnings released on 24 Feb 2022
EPS came in at -$0.45 surpassing the estimated -$0.51 by +11.76%, while revenue for the quarter reached $20.68m , beating expectations by +0.79%.
Earnings released on 4 Nov 2021
EPS came in at -$0.40 matching the estimated -$0.40, while revenue for the quarter reached $22.26m , beating expectations by +0.73%.
Earnings released on 4 Aug 2021
EPS came in at -$0.34 surpassing the estimated -$0.39 by +12.82%, while revenue for the quarter reached $21.67m , meeting expectations.
PSNL Stock Performance
Access detailed PSNL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
